One of Medicine's Ugly Little Secrets.
SierraTimes.com - 16 Nov 2002
... Even your doctor doesn't want to hear it, or has no idea there's any such thing
- just take some Wellbutrin and see how high you register on a seismograph. ...

Nerve disease morphs to daily pain
West County Times, CA - 12 Nov 2002
... less burdensome. Pamelor, Norpramin and Wellbutrin are three antidepressant
medicines that can often dampen nerve pain. Spinal-cord ...

Player faces mental woes, but gets to stay on team
Cincinnati Enquirer, OH - 09 Nov 2002
... His doctors have taken him off Prozac and Wellbutrin, the medications
he swallowed as an impulsive act. Swartz's OCD has evolved. ...

Smoking not an easy tiger to tame
Oregonian, OR - 07 Nov 2002
... said. Two anti-depressants, Zyban and Wellbutrin, are proving to be
the most effective drugs in a smoker's fight to quit, Arle said. ...

Women are quitters and proud of it
Amarillo Globe News, TX - 07 Nov 2002
... plans. Turner intended to use patches, and Smith was going to use Wellbutrin,
a prescription medication, to help diminish cravings. ...

Smoking not an easy tiger to tame
Oregonian, OR - 07 Nov 2002
... said. Two anti-depressants, Zyban and Wellbutrin, are proving to be
the most effective drugs in a smoker's fight to quit, Arle said. ...

Andrx Shares Rally as Investors Pin Hopes on Generic-Drug ...
Quicken - 01 Nov 2002
... Andrx could receive final approval and launch generic versions of GlaxoSmithKline
PLC's (GSK, news) depression drug Wellbutrin SR, smoking-cessation drug Zyban ...

Andrx Maneuvers to Circumvent Prilosec Ruling
Smart Money - 01 Nov 2002
... Andrx said it was confident the Food and Drug Administration would approve its generic
versions of GlaxoSmithKline PLC's (GSK) depression drug Wellbutrin and ...

Andrx Maneuvers to Circumvent Prilosec Ruling
Smart Money - 01 Nov 2002
... Andrx said it was confident the Food and Drug Administration would approve its generic
versions of GlaxoSmithKline PLC's (GSK) depression drug Wellbutrin and ...

Andrx Reports Loss, Hurt by Drug Delays
ABC News - 31 Oct 2002
... court or regulatory decisions on whether it can market a slew of copycat drugs, including
hypertension drug Tiazac, lucrative depression drug Wellbutrin SR and ...

Andrx Reports Loss, Hurt by Drug Delays
Reuters, UK - 31 Oct 2002
... court or regulatory decisions on whether it can market a slew of copycat drugs, including
hypertension drug Tiazac, lucrative depression drug Wellbutrin SR and ...

Andrx Reports Loss, Hurt by Drug Delays
ABC News - 31 Oct 2002
... also awaiting court or regulatory decisions on whether it can market a slew of copycat
versions, including hypertension drug Tiazac, depression drug Wellbutrin ...

Andrx Reports Loss, Hurt by Drug Delays
Reuters, UK - 31 Oct 2002
... also awaiting court or regulatory decisions on whether it can market a slew of copycat
versions, including hypertension drug Tiazac, depression drug Wellbutrin ...

Basketball star battles debilitating disorder
Green Bay Press Gazette, WI - 31 Oct 2002
... same.”. His doctors have taken him off the medication — Prozac
and Wellbutrin — he swallowed that morning before practice. ...

Biovail's earnings climb by 127%
Montreal Gazette, Canada - 30 Oct 2002
... developmental milestone with the August filing of a new drug application by GlaxoSmithKline
for our once-daily formulation of (anti-depressant) Wellbutrin ...

Drug company Biovail reports 127% rise in third-quarter profit
CBC News, Canada - 29 Oct 2002
... Tuesday. our once-daily formulation of (anti-depressant) Wellbutrin,"
Eugene Melnyk, chairman and chief executive, said in a release. ...

Drug company Biovail reports 127% rise in third-quarter profit
Waterloo Record, Canada - 29 Oct 2002
... Tuesday. our once-daily formulation of (anti-depressant) Wellbutrin,"
Eugene Melnyk, chairman and chief executive, said in a release. ...

Biovail reports 127% rise in third-quarter profit
Toronto Star, Canada - 29 Oct 2002
... developmental milestone with the August filing of a new drug application by GlaxoSmithKline
for our once-daily formulation of (anti-depressant) Wellbutrin ...

Drug company Biovail reports 127% rise in third-quarter profit
Waterloo Record, Canada - 29 Oct 2002
... developmental milestone with the August filing of a new drug application by GlaxoSmithKline
for our once-daily formulation of (anti-depressant) Wellbutrin ...

Biovail sees higher Q3 earnings
CBC News, Canada - 29 Oct 2002
... another significant developmental milestone with the August filing of a new drug
application by GlaxoSmithKline for our once-daily formulation of Wellbutrin ...

Drug company Biovail reports 127% rise in third-quarter profit
CBC News, Canada - 29 Oct 2002
... developmental milestone with the August filing of a new drug application by GlaxoSmithKline
for our once-daily formulation of (anti-depressant) Wellbutrin ...

Drug company Biovail reports 127% rise in third-quarter profit
Ottawa Citizen, Canada - 29 Oct 2002
... developmental milestone with the August filing of a new drug application by GlaxoSmithKline
for our once-daily formulation of (anti-depressant) Wellbutrin ...

Drug company Biovail reports 127% rise in third-quarter profit
St. Catherines Standard, Canada - 29 Oct 2002
... developmental milestone with the August filing of a new drug application by GlaxoSmithKline
for our once-daily formulation of (anti-depressant) Wellbutrin ...

Drug company Biovail reports 127% rise in third-quarter profit
Canada.com, Canada - 29 Oct 2002
... developmental milestone with the August filing of a new drug application by GlaxoSmithKline
for our once-daily formulation of (anti-depressant) Wellbutrin ...

Drug company Biovail reports 127% rise in third-quarter profit
CBC News, Canada - 29 Oct 2002
... developmental milestone with the August filing of a new drug application by GlaxoSmithKline
for our once-daily formulation of (anti-depressant) Wellbutrin ...

Biovail Reports Record Third Quarter 2002 Results
StockHouse Canada, Canada - 29 Oct 2002
... another significant developmental milestone with the August filing of a New Drug
Application by GlaxoSmithKline for our once-daily formulation of Wellbutrin. ...

Exelixis, GlaxoSmithKline Form Alliance
Reuters, UK - 28 Oct 2002
... Glaxo has been struggling with cheap generic rivals to its top-selling drugs, like
the antibiotic Augmentin and anti-depressant Wellbutrin, and doubts about ...

Exelixis, GlaxoSmithKline Form Alliance
ABC News - 28 Oct 2002
... Glaxo has been struggling with cheap generic rivals to its top-selling drugs, like
the antibiotic Augmentin and anti-depressant Wellbutrin, and doubts about ...

GSK shares fall on Q3 figures
The Scotsman, UK - 23 Oct 2002
... GSK’s fate has mirrored the sector, with key products such as antibiotic Augmentin
and anti-depressant Wellbutrin losing market exclusivity, and impotence ...

GlaxoSmithKline spends £ 4bn to boost shares
Guardian, UK - 23 Oct 2002
... Glaxo's popular anti-depressant Wellbutrin has also lost its patent protection
and the company is facing patent challenges to another top-selling anti ...

GlaxoSmithKline Profit Surges
TheStreet.com, NY - 23 Oct 2002
... on the nervous system rose 21% to $1.7 billion in the quarter, with sales of antidepressant
Paxil, its biggest drug, up 27% in the US and sales of Wellbutrin ...

Glaxo Share Buyback Fails to Dull Pain
ABC News - 23 Oct 2002
... Glaxo's fate has mirrored the sector, with key products like antibiotic Augmentin
and anti-depressant Wellbutrin losing market exclusivity, and impotence ...

GSK share buyback fails to dull Q3 pain
Reuters AlertNet, UK - 23 Oct 2002
... Glaxo's fate has mirrored the sector, with key products like antibiotic Augmentin
and anti-depressant Wellbutrin losing market exclusivity, and impotence ...

Glaxo Share Buyback Fails to Dull Pain
Reuters, UK - 23 Oct 2002
... Glaxo's fate has mirrored the sector, with key products like antibiotic Augmentin
and anti-depressant Wellbutrin losing market exclusivity, and impotence ...

Bush's drug plan meets with skepticism
Raleigh News, NC - 22 Oct 2002
... Currently, in addition to Paxil, it is fighting patent battles over the anti-depressant
Wellbutrin, the antibiotic Ceftin and the anti-nausea drug Zofran. ...